Grammy winner Nelly Furtado quits performing for ‘foreseeable future’ following body-shaming criticism ...
Multigene next-generation sequencing (NGS) performed directly on tumor tissue can accurately identify pathogenic variants in epithelial ovarian cancer (EOC), detecting both somatic and germline ...
Stomach cancer is challenging to detect early due to vague symptoms, often diagnosed at advanced stages. Diagnosis involves ...
In this innovation-focused webinar, we’ll explore how syndromic testing is transforming the diagnostic and clinical management of bloodstream infections (BSIs). Featuring real-world ex ...
In the study, researchers molecularly screened nearly 2,000 cancer patients and matched 14 percent into a study arm.
The Las Vegas Medical District is set to expand with a new testing facility that officials say will strengthen the region’s ...
Texas A&M researchers found that in an aggressive kidney cancer, RNA builds “droplet hubs” that activate tumor genes. By creating a molecular switch to dissolve these hubs, they stopped cancer growth ...
Study Acceptance Supports and Provides the Catalyst for Upcoming Commercial Rollout and Revenue-Generating Potential ...
Data at ESMO 2025 bolstered the case that blood tests could help doctors sort which patients need additional therapy, and who ...
Although COVID-19 testing decreased during the study period, influenza and respiratory syncytial virus testing increased among hospitalized youth.
A blood test that screens for more than 50 cancers is correct in nearly two thirds of cases where it thinks people may have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback